HIV Treatment Reduces Accelerated Biological Aging by Nearly Four Years

A major study presented at ESCMID Global 2026 demonstrates that antiretroviral therapy (ART) reduces accelerated biological aging in people with HIV by nearly four years. The research, unveiled at the European Society of Clinical Microbiology and Infectious Diseases conference, represents a significant advancement in understanding the broader health benefits of HIV treatment beyond viral suppression. The finding could fundamentally transform how clinicians monitor both HIV treatment efficacy and long-term health outcomes in patients living with the virus. This discovery highlights that ART not only controls HIV infection but also addresses the accelerated aging process associated with the disease.

Impact of antiretroviral therapy on biological aging in HIV patients

• ▪The study on antiretroviral therapy's impact on biological aging in people with HIV was described as a major study
• ▪A study presented at ESCMID Global 2026 found that antiretroviral therapy reduces accelerated biological aging in people with HIV by nearly four years

Clinical implications for HIV treatment monitoring

• ▪The finding that antiretroviral therapy reduces accelerated biological aging in people with HIV by nearly four years could transform how clinicians monitor HIV treatment